Science Explorer Back to mapMap
Discussion
Company · Ballerup Municipality · Denmark

Leo Pharma (Denmark)

In research, Leo Pharma (Denmark) stands highest in Health Sciences (#5,695 of 16,688 worldwide), Life Sciences (#4,175 of 11,023 worldwide) and Medicine (#5,720 of 14,558 worldwide), over all time.

leo-pharma.comROR OpenAlex
World rank, all time
#12,373
of 34,923
Rank in Denmark
#78
of 179
Research works
635
▼ 33% vs 2018-21
Citations
18k
28.0 per fractional work
Top-10% rate
15.2%
all institutions 10.0%
vs its own fields
0.98×
1.00× is exactly expected
Open access
30%
world 40%
International
33%
world 18%
Leo Pharma (Denmark)

What is Leo Pharma (Denmark) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #5,695 of 16,688 10.5%303
Life SciencesDomain #4,175 of 11,023 8.8%251
MedicineField #5,720 of 14,558 10.8%284
Biochemistry, Genetics and Molecular BiologyField #2,584 of 5,801 9.4%124

Each strip is that field's whole ranked pool, with the notch where Leo Pharma (Denmark) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Leo Pharma (Denmark) work in?

In 2022-now, 52% of research at Leo Pharma (Denmark) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (50%), Immunology and Microbiology (20%), Biochemistry, Genetics and Molecular Biology (8%). It does 2.1× the world's share of Life Sciences.

Health Sciences: 31 fractional works · 52.2% of its workMedicine: 30 fractional works · 50.4% of its workDermatology: 14 fractional works · 24.2% of its workRheumatology: 3 fractional works · 4.4% of its workImmunology and Allergy: 2 fractional works · 3.9% of its workPhysiology: 2 fractional works · 3.5% of its workEpidemiology: 1 fractional works · 2.3% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.5% of its workOncology: 1 fractional works · 1.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.1% of its workSurgery: 1 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.8% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workFamily Practice: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workInternal Medicine: 0 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 1.3% of its workEmergency Medical Services: 0 fractional works · 0.8% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.2% of its workLife Sciences: 19 fractional works · 32.6% of its workImmunology and Microbiology: 12 fractional works · 19.5% of its workImmunology: 12 fractional works · 19.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 8.2% of its workMolecular Biology: 3 fractional works · 5.7% of its workCell Biology: 0 fractional works · 0.7% of its workBiotechnology: 0 fractional works · 0.6% of its workBiophysics: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.5% of its workCancer Research: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 3.0% of its workPharmaceutical Science: 1 fractional works · 1.6% of its workToxicology: 1 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 1 fractional works · 1.7% of its workFood Science: 0 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.6% of its workInsect Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.2% of its workPhysical Sciences: 7 fractional works · 11.4% of its workMathematics: 2 fractional works · 3.4% of its workStatistics and Probability: 2 fractional works · 3.4% of its workChemistry: 2 fractional works · 2.6% of its workOrganic Chemistry: 1 fractional works · 1.7% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 2 fractional works · 2.6% of its workBiomedical Engineering: 1 fractional works · 0.9% of its workControl and Systems Engineering: 0 fractional works · 0.8% of its workAerospace Engineering: 0 fractional works · 0.3% of its workComputational Mechanics: 0 fractional works · 0.3% of its workOcean Engineering: 0 fractional works · 0.3% of its workChemical Engineering: 0 fractional works · 0.8% of its workFluid Flow and Transfer Processes: 0 fractional works · 0.6% of its workProcess Chemistry and Technology: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.6% of its workStatistical and Nonlinear Physics: 0 fractional works · 0.6% of its workEnvironmental Science: 0 fractional works · 0.5% of its workGlobal and Planetary Change: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workComputer Science: 0 fractional works · 0.4% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.4% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 3.8% of its workEconomics, Econometrics and Finance: 2 fractional works · 2.8% of its workEconomics and Econometrics: 2 fractional works · 2.8% of its workDecision Sciences: 0 fractional works · 0.6% of its workManagement Science and Operations Research: 0 fractional works · 0.3% of its workInformation Systems and Management: 0 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.1% of its workALL ITS WORKLeo Pharma(Denmark)59fractional works, 2022-now
Life Sciences33%Physical Sciences11%Health Sciences52%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Medicine3050.4%
    2. Health Professions11.3%
    3. Nursing00.3%
    4. Veterinary00.2%
    1. Immunology and Microbiology1219.5%
    2. Biochemistry, Genetics and Molecular Biology58.2%
    3. Pharmacology, Toxicology and Pharmaceutics23.0%
    4. Agricultural and Biological Sciences11.7%
    5. Neuroscience00.2%
    1. Mathematics23.4%
    2. Chemistry22.6%
    3. Engineering22.6%
    4. Chemical Engineering00.8%
    5. Physics and Astronomy00.6%
    6. Environmental Science00.5%
    7. Computer Science00.4%
    8. Energy00.4%
    9. Materials Science00.1%
    1. Economics, Econometrics and Finance22.8%
    2. Decision Sciences00.6%
    3. Arts and Humanities00.1%
    4. Business, Management and Accounting00.1%
    5. Psychology00.1%
    6. Social Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.36× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.54× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 19.36× its world share, 12 worksImmunology and Micro…Neuroscience: 0.11× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.41× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 2.40× its world share, 0 worksChemical EngineeringChemistry: 1.67× its world share, 2 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEnergy: 0.43× its world share, 0 worksEnergyEngineering: 0.17× its world share, 2 worksEngineeringEnvironmental Science: 0.09× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 0 worksMaterials ScienceMathematics: 2.91× its world share, 2 worksMathematicsPhysics and Astronomy: 0.25× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.48× its world share, 1 worksHealth ProfessionsMedicine: 2.62× its world share, 30 worksMedicineNursing: 0.57× its world share, 0 worksNursingVeterinary: 1.37× its world share, 0 worksVeterinaryArts and Humanities: 0.05× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.04× its world share, 0 worksBusiness, Management…Decision Sciences: 0.60× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.30× its world share, 2 worksEconomics, Econometr…Psychology: 0.05× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 19.4×. Every wedge is a field page.

All 24 fields, with their numbers
  1. Immunology and Microbiology19.36×12 works
  2. Pharmacology, Toxicology and Pharmaceutics8.41×2 works
  3. Mathematics2.91×2 works
  4. Medicine2.62×30 works
  5. Chemical Engineering2.40×0 works
  6. Chemistry1.67×2 works
  7. Biochemistry, Genetics and Molecular Biology1.54×5 works
  8. Veterinary1.37×0 works
  9. Economics, Econometrics and Finance1.30×2 works
  10. Decision Sciences0.60×0 works
  11. Nursing0.57×0 works
  12. Health Professions0.48×1 works
  13. Energy0.43×0 works
  14. Agricultural and Biological Sciences0.36×1 works
  15. Physics and Astronomy0.25×0 works
  16. Engineering0.17×2 works
  17. Neuroscience0.11×0 works
  18. Environmental Science0.09×0 works
  19. Computer Science0.05×0 works
  20. Arts and Humanities0.05×0 works
  21. Psychology0.05×0 works
  22. Materials Science0.04×0 works
  23. Business, Management and Accounting0.04×0 works
  24. Social Sciences0.01×0 works

Who are the top researchers at Leo Pharma (Denmark)?

Ranked on the quality score, David Adrian Ewald, Paola Lovato and Jakob Felding lead among researchers whose main affiliation is Leo Pharma (Denmark).

  1. 1 David Adrian Ewald Denmark · #568,536 worldwide 1.6k citations · 40 works
  2. 2 Paola Lovato Denmark · #594,101 worldwide 1.9k citations · 48 works
  3. 3 Jakob Felding Denmark · #680,879 worldwide 2k citations · 58 works
  4. 4 Marie Louise Østerdal Denmark · #748,447 worldwide 2k citations · 32 works
  5. 5 Karsten Petersson Denmark · #982,104 worldwide 2k citations · 24 works
  6. 6 Julie Hviid Hahn-Pedersen Denmark · #1,062,449 worldwide 657 citations · 32 works
  7. 7 Bleuenn Rault Denmark · #1,297,763 worldwide 105 citations · 18 works
  8. 8 Leif Tybring Denmark · #1,320,537 worldwide 1.2k citations · 27 works
  9. 9 Sebastian Clementson Denmark · #1,351,863 worldwide 403 citations · 31 works
  10. 10 Britta Cathrina Martel Denmark · #1,371,173 worldwide 354 citations · 15 works
All ranked researchers at Leo Pharma (Denmark)

What are the most cited papers from Leo Pharma (Denmark)?

The most cited paper from Leo Pharma (Denmark) is "The role of lipid components in lipid nanoparticles for vaccines and gene therapy" (Camilla Hald Albertsen, Jayesh A. Kulkarni, Dominik Witzigmann et al., 2022), with 1,183 citations. Next come "Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*" (627) and "Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer" (615).

Most cited papers
#PaperReleasedCitations
1 The role of lipid components in lipid nanoparticles for vaccines and gene therapy Camilla Hald Albertsen, Jayesh A. Kulkarni, Dominik Witzigmann et al. · Advanced Drug Delivery Reviews ReviewOpen access 3 Jul 2022 1,183
2 Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)* Andreas Wollenberg et al. · British Journal of Dermatology Open access Oct 2020 627
3 Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer Agnes Y. Y. Lee, Pieter Willem Kamphuisen, Guy Meyer et al. · JAMA Open access 18 Aug 2015 615
4 A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis Gabriele Siegel et al. · Nature Cell Biology Open access 24 May 2009 493
5 Ingenol Mebutate Gel for Actinic Keratosis Mark Lebwohl, Neil A. Swanson, Lawrence L. Anderson et al. · New England Journal of Medicine Open access 14 Mar 2012 472
All 60 most cited papers, with filters and sorting

Which keywords describe research at Leo Pharma (Denmark)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immune Dysregulation, Filaggrin, Skin Microbiome, Epidemiology, Regulatory T Cells, Immune System, TGF-ß and Inflammatory Cytokines.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology11▲ 4.6×18 topics
  2. Immune Dysregulation9▲ 186×2 topics
  3. Filaggrin9▲ 295×1 topic
  4. Skin Microbiome9▲ 295×1 topic
  5. Regulatory T Cells7▲ 100×2 topics
  6. Immune System6▲ 46×6 topics
  7. TGF-ß6▲ 67×2 topics
  8. Inflammatory Cytokines6▲ 118×2 topics
  9. IL-176▲ 285×1 topic
  10. TH17 Cells6▲ 285×1 topic
  11. Inflammation4▲ 3.6×16 topics
  12. Quality of Life4▲ 4.9×6 topics
  13. Diagnosis4▲ 7.4×7 topics
  14. Risk Assessment4▲ 9.7×2 topics
  15. Contact Allergy4▲ 334×1 topic
  16. Skin Sensitization4▲ 334×1 topic
  17. Management4▲ 7.3×5 topics
  18. Treatment4▲ 4.8×7 topics
  19. Asthma3▲ 56×2 topics
  20. Genetics2▲ 5.6×5 topics
  21. Allergic Diseases2▲ 59×1 topic
  22. Eosinophils2▲ 59×1 topic
  23. Immunology2▲ 33×2 topics
  24. Autoantibodies2▲ 13×4 topics
  25. Prevalence2▲ 6.6×4 topics
  26. Adverse Drug Reactions2▲ 47×3 topics
  27. Autoimmune2▲ 57×2 topics
  28. Children2▲ 11×2 topics
  29. NK Cell Recognition2▲ 41×1 topic
  30. Natural Killer Cells2▲ 41×1 topic
  31. Chronic Spontaneous Urticaria1▲ 116×1 topic
  32. Urticaria1▲ 116×1 topic
  33. Glycosylation1▲ 21×3 topics
  34. Innate Immunity1▲ 6.9×2 topics
  35. Monoclonal Antibodies1▲ 24×3 topics
  36. Anaphylaxis1▲ 82×1 topic
  37. Cancer Immunotherapy1▲ 13×2 topics
  38. Cost-effectiveness Analysis1▲ 26×1 topic
  39. Food Allergy1▲ 82×1 topic
  40. Health Utility Measures1▲ 26×1 topic

Which research topics does Leo Pharma (Denmark) publish most on?

By volume in 2022-now: Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Contact Dermatitis and Allergies and Asthma and respiratory diseases.

Dermatology and Skin Dis…9Dermatology and Skin Diseases: 9 fractional worksPsoriasis: Treatment and…6Psoriasis: Treatment and Pathogenesis: 6 fractional worksContact Dermatitis and A…4Contact Dermatitis and Allergies: 4 fractional worksAsthma and respiratory diseases: 2 fractional worksImmune Cell Function and Interaction: 2 fractional worksUrticaria and Related Conditions: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksAdvanced Causal Inference Techniques: 1 fractional worksFood Allergy and Anaphylaxis Research: 1 fractional worksAllergic Rhinitis and Sensitization: 1 fractional works
DermatologyImmunologyPhysiologyRheumatology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Dermatology and Skin Diseases Dermatology 9 works
  2. 2 Psoriasis: Treatment and Pathogenesis Immunology 6 works
  3. 3 Contact Dermatitis and Allergies Dermatology 4 works
  4. 4 Asthma and respiratory diseases Physiology 2 works
  5. 5 Immune Cell Function and Interaction Immunology 2 works
  6. 6 Urticaria and Related Conditions Rheumatology 1 works
  7. 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  8. 8 Advanced Causal Inference Techniques Statistics and Probability 1 works
  9. 9 Food Allergy and Anaphylaxis Research Immunology and Allergy 1 works
  10. 10 Allergic Rhinitis and Sensitization Immunology and Allergy 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.8%not open70.2%

World: 40% of research is openly available.

with international co-authors33.2%domestic only66.8%

World: 18% is written across borders.

How has Leo Pharma (Denmark)'s research output changed?

Output in 2022-2025 was 33% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Leo Pharma (Denmark) as a percentage of every work published that year, 0.00023% in 2024.

still counting0.0020%0.0040%0.0060%Leo Pharma (Denmark)0.00016% in 202519801990200020102020

Fractional works of Leo Pharma (Denmark) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Ballerup Municipality

All research institutions in Ballerup Municipality

Share Leo Pharma (Denmark)'s ranking

Leo Pharma (Denmark) on Science Explorer

A card with Leo Pharma (Denmark)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Leo Pharma (Denmark). Posts are plain text and can be reported.